What is the NOAEL for Diphenhydramine hydrochloride?
Diphenhydramine hydrochloride has 37 NOAEL studies in the database. The lowest reported value is 0 uL/min/10^6 cells in Human. Source: NTP ICE adme parameters.
Also known as: Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride, Difenhydramine hydrochloride, Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride (1:1), Ambenyl, Bendylate (+14 more)
CAS 147-24-0
Diphenhydramine hydrochloride (CAS 147-24-0) is a chemical substance. Key regulatory status: 3 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat.
Diphenhydramine hydrochloride is prohibited in EU cosmetics but has active industrial GHS classifications (H302, H361, H362, H370, H372, H373).
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| detected; MN Chemical Screening; surface_water | Minnesota Pollution Control Agency | State of Minnesota |
| active_ingredient; Australia | Australian Pesticides and Veterinary Medicines Authority | CPCat |
| Canada; Personal care; Substances in PCP - Canada (4/2014) | Government of Canada | CPCat |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 0 | uL/min/10^6 cells | Clint | - | Human | NTP ICE adme parameters |
| TC2D6JAD40 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 0.4131 | fraction | Fu | - | Human | NTP ICE adme parameters |
| 0 | % | Incidence of positive responses | Dermal | Human | NTP ICE skin sensitization |
| 1.552e+4 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP ICE skin sensitization |
| =500 | mg/kg bw | LD50 | oral | Rat | NTP ICE acute oral |
| =7 | mg/kg bw/day | LEL | oral | Rat | ToxValDB ToxRefDB |
| =7 | mg/kg bw/day | LEL | oral | rat (fischer; Fischer 344) | EPA ToxRefDB v3 |
| =13 | mg/kg bw/day | LEL | oral | Rat | ToxValDB ToxRefDB |
| =13 | mg/kg bw/day | LEL | oral | rat (fischer; Fischer 344) | EPA ToxRefDB v3 |
| =15.7 | mg/kg bw/day | LEL | oral | Rat | ToxValDB ToxRefDB |
| =15.7 | mg/kg bw/day | LEL | oral | rat (fischer; Fischer 344) | EPA ToxRefDB v3 |
| =21 | mg/kg bw/day | LEL | oral | Mouse | ToxValDB ToxRefDB |
| =21 | mg/kg bw/day | LEL | oral | mouse (b6c3f1; B6C3F1) | EPA ToxRefDB v3 |
| =93.8 | mg/kg bw/day | LEL | oral | Mouse | ToxValDB ToxRefDB |
| =93.8 | mg/kg bw/day | LEL | oral | mouse (b6c3f1; B6C3F1) | EPA ToxRefDB v3 |
| =31.3 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB ToxRefDB |
| =31.3 | mg/kg bw/day | LOAEL | oral | rat (fischer; Fischer 344) | EPA ToxRefDB v3 |
| =46 | mg/kg bw/day | LOAEL | oral | Mouse | ToxValDB ToxRefDB |
| =46 | mg/kg bw/day | LOAEL | oral | mouse (b6c3f1; B6C3F1) | EPA ToxRefDB v3 |
| =47 | mg/kg bw/day | LOAEL | oral | Mouse | ToxValDB ToxRefDB |
| =47 | mg/kg bw/day | LOAEL | oral | mouse (b6c3f1; B6C3F1) | EPA ToxRefDB v3 |
| 0 | unitless | Model Score | - | - | NTP ICE endocrine |
| >0 | mg/kg bw/day | NEL | oral | rat (fischer; Fischer 344) | EPA ToxRefDB v3 |
| =7.8 | mg/kg bw/day | NEL | oral | Rat | ToxValDB ToxRefDB |
| =7.8 | mg/kg bw/day | NEL | oral | rat (fischer; Fischer 344) | EPA ToxRefDB v3 |
| =47 | mg/kg bw/day | NEL | oral | Mouse | ToxValDB ToxRefDB |
| =47 | mg/kg bw/day | NEL | oral | mouse (b6c3f1; B6C3F1) | EPA ToxRefDB v3 |
| =0.6 | mg/L | NOEC | environmental | Rat | ToxValDB ECOTOX |
| =2 | mg/L | NOEC | environmental | Rat | ToxValDB ECOTOX |
| =5 | mg/L | NOEC | environmental | Rat | ToxValDB ECOTOX |
| =6 | mg/L | NOEC | environmental | Rat | ToxValDB ECOTOX |
| =10 | mg/L | NOEC | environmental | Rat | ToxValDB ECOTOX |
| =20 | mg/L | NOEC | environmental | Rat | ToxValDB ECOTOX |
| 1 | unitless | Relative reliability score | Dermal | Human | NTP ICE skin sensitization |
| 313 | ppm | Top dose | Dosed feed | Mouse | NTP ICE cancer |
| 625 | ppm | Top dose | Dosed feed | Rat | NTP ICE cancer |
Showing 37 of 37 studies
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Diphenhydramine hydrochloride has 37 NOAEL studies in the database. The lowest reported value is 0 uL/min/10^6 cells in Human. Source: NTP ICE adme parameters.
Diphenhydramine hydrochloride appears on 3 regulatory/inventory lists including detected; MN Chemical Screening; surface_water, active_ingredient; Australia, Canada; Personal care; Substances in PCP - Canada (4/2014). Source: EPA CPDat.
Yes, Diphenhydramine hydrochloride is also indexed as a cosmetic ingredient under the name Diphenhydramine HCl. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, EPA DSSTox, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Diphenhydramine hydrochloride is prohibited in EU cosmetics but has active industrial GHS classifications (H302, H361, H362, H370, H372, H373).
Diphenhydramine hydrochloride also appears in cosmetics, pharmaceutical databases.